WADA Prohibited Compounds in This Catalog

Catalog entries whose compounds appear on, or fall under classes of, the World Anti-Doping Agency Prohibited List. Athletes subject to testing should treat this table as a starting point, not a substitute for the current official list.

Compound / class	WADA category	Notes
Somatropin (GH)	S2 — Peptide hormones	Prohibited at all times
GH-releasing factors: sermorelin, tesamorelin, CJC-1295 variants	S2 — Peptide hormones	Releasing factors prohibited at all times
GHRP family: ipamorelin, GHRP-2, GHRP-6, hexarelin	S2 — Peptide hormones	Ghrelin receptor agonists prohibited
Ibutamoren (MK-677)	S2 — Peptide hormones	GH secretagogue, prohibited
IGF-1 and analogs: LR3, DES, MGF, PEG-MGF	S2 — Peptide hormones	Growth factors prohibited
Erythropoietin (EPO)	S2 — Peptide hormones	ESAs prohibited at all times
HCG and HMG	S2 — Peptide hormones	Prohibited at all times in males
Gonadorelin, triptorelin	S2 — Peptide hormones	GnRH-related releasing factors
Insulin	S2 — Peptide hormones	Prohibited except with therapeutic use exemption
AICAR	S4 — Hormone and metabolic modulators	AMPK activator, prohibited
Synthetic oxygen carriers and any non-approved substance	Section 0 / S0 categories	Any drug not approved for human therapeutic use is prohibited by default

This table is a navigation aid into the entry pages, which carry full evidence and safety context for each compound.

Dr. Elena Marsh, PhDMolecular Pharmacology · Lead Editor

Written and maintained by the editorial team. Medically reviewed by Dr. James Okafor, MD (Internal Medicine).

Evidence tier: Approved medicine · Last reviewed: 2026-09-05 · Sources cited below.